Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Study ID: NCT04067830
Start Date: 2019-03-20
End Date: 2026-03-22
Study Type

Interventional

Study Phase

Phase2

No. of Participants

220

Intervention / Treatment

Best Practice

Laparoscopic Surgery

Quality-of-Life Assessment

Administration questionnaire

Respiratory Muscle Training Device

Video-Assisted Thoracic Surgery

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Telehealth and Memory Study

Study ID: NCT04586530
Start Date: 2021-03-18
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Memory and Attention Adaptation Training (MAAT)

Supportive Therapy (ST)

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

Study ID: NCT04606030
Start Date: 2020-10-26
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

BioBridge® Collagen Matrix

Vascularized Lymph Node Transfer (VLNT)

Sponsor

Fibralign Corporation

Source: clinicaltrials.gov

Share:
Add to list

BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-NHL

Study ID: NCT05370430
Start Date: 2022-06-13
End Date: 2028-06-13
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

BAFFR-CAR T cells

Sponsor

Pepromene Bio, Inc.

Source: clinicaltrials.gov

Share:
Add to list

SABER Study for Selected Early Stage Breast Cancer

Study ID: NCT04360330
Start Date: 2020-08-05
End Date: 2028-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

18

Intervention / Treatment

Stereotactic Ablative Breast Radiotherapy

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer

Study ID: NCT04523857
Start Date: 2021-11-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Abemaciclib

Hydroxychlorine

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Study ID: NCT06789848
Start Date: 2025-02-18
End Date: 2030-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

64

Intervention / Treatment

Ligufalimab

Cadonilimab

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum

Study ID: NCT01042548
Start Date: 2010-02-03
End Date: 2028-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

Study ID: NCT05799248
Start Date: 2023-04-27
End Date: 2024-05-28
Study Type

Interventional

Study Phase

Phase3

No. of Participants

113

Intervention / Treatment

rhPSMA-7.3 (18F)

Sponsor

MidLantic Urology

Source: clinicaltrials.gov

Share:
Add to list

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Study ID: NCT05877430
Start Date: 2023-09-11
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

Cjrb-101

Pembrolizumab injection

Sponsor

CJ Bioscience, Inc.

Source: clinicaltrials.gov

Share:
Add to list